CCI
Columbus Circle Investors Portfolio holdings
AUM
$2.28B
This Quarter Return
+9.51%
1 Year Return
+135.58%
3 Year Return
+366.07%
5 Year Return
+793.68%
10 Year Return
–
AUM
$12.3B
AUM Growth
+$12.3B
(+2%)
Cap. Flow
-$152M
Cap. Flow
% of AUM
-1.24%
Top 10 Holdings %
Top 10 Hldgs %
24.44%
Holding
326
New
56
Increased
111
Reduced
92
Closed
64
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
$213M |
| 2 |
Nike
NKE
|
$138M |
| 3 |
Edwards Lifesciences
EW
|
$87.4M |
| 4 |
Synchrony
SYF
|
$84.6M |
| 5 |
Visteon
VC
|
$63.7M |
Top Sells
| 1 |
Morgan Stanley
MS
|
$137M |
| 2 |
Estee Lauder
EL
|
$121M |
| 3 |
AGN
Allergan plc
AGN
|
$109M |
| 4 |
Yum! Brands
YUM
|
$106M |
| 5 |
Illumina
ILMN
|
$103M |
Sector Composition
| 1 | Healthcare | 24.12% |
| 2 | Consumer Discretionary | 21.19% |
| 3 | Technology | 18.92% |
| 4 | Financials | 10.09% |
| 5 | Communication Services | 7.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Amicus Therapeutics
FOLD
$2.34B
| $2.21M | 0.02% | 227,889 +125,574 | +123% | +$1.22M |
|
|
RVNC
227
DELISTED
Revance Therapeutics, Inc.
RVNC
| $2.09M | 0.02% | 61,295 +35,734 | +140% | +$1.22M |
|
228
DHT Holdings
DHT
$1.88B
| $2.02M | 0.02% | 250,000 +50,000 | +25% | +$405K |
|
229
iShares Russell 1000 Growth ETF
IWF
$116B
| $2M | 0.02% | +20,110 | New | +$2M |
|
230
uniQure
QURE
$896M
| $1.88M | 0.02% | 113,548 +94,422 | +494% | +$1.56M |
|
|
IPHI
231
DELISTED
INPHI CORPORATION
IPHI
| $1.55M | 0.01% | 57,406 +31,826 | +124% | +$860K |
|
|
AERI
232
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $1.52M | 0.01% | 62,457 -13,299 | -18% | -$324K |
|
233
Acadia Healthcare
ACHC
$2.12B
| $1.52M | 0.01% | 24,260 +6,202 | +34% | +$387K |
|
234
Acadia Pharmaceuticals
ACAD
$4.38B
| $1.38M | 0.01% | +38,607 | New | +$1.38M |
|
235
Rocket Pharmaceuticals
RCKT
$354M
| $1.37M | 0.01% | 120,867 -73,290 | -38% | -$830K |
|
236
Synaptics
SYNA
$2.7B
| $1.22M | 0.01% | 15,125 +4,155 | +38% | +$334K |
|
237
Trimble
TRMB
$19.2B
| $1.16M | 0.01% | +53,956 | New | +$1.16M |
|
238
Catalyst Pharmaceutical
CPRX
$2.52B
| $1.03M | 0.01% | 418,384 -146,275 | -26% | -$358K |
|
|
AKRX
239
DELISTED
Akorn, Inc.
AKRX
| $1.01M | 0.01% | 27,142 -6,051 | -18% | -$226K |
|
240
Ocular Therapeutix
OCUL
$2.12B
| $964K | 0.01% | 102,859 +36,747 | +56% | +$344K |
|
241
Hewlett Packard
HPE
$29.6B
| $955K | 0.01% | +62,823 | New | +$955K |
|
|
AMSG
242
DELISTED
Amsurg Corp
AMSG
| $931K | 0.01% | +12,256 | New | +$931K |
|
|
AMED
243
DELISTED
Amedisys
AMED
| $914K | 0.01% | +23,245 | New | +$914K |
|
|
AVDL
244
Avadel Pharmaceuticals
AVDL
$1.43B
| $896K | 0.01% | 73,415 -30,420 | -29% | -$371K |
|
245
Natera
NTRA
$23.1B
| $729K | 0.01% | +67,481 | New | +$729K |
|
|
INXN
246
DELISTED
Interxion Holding N.V.
INXN
| $713K | 0.01% | +23,650 | New | +$713K |
|
|
PETX
247
DELISTED
Aratana Therapeutics, Inc.
PETX
| $694K | 0.01% | 124,439 -878,224 | -88% | -$4.9M |
|
248
HealthEquity
HQY
$7.72B
| $677K | 0.01% | +27,003 | New | +$677K |
|
249
MACOM Technology Solutions
MTSI
$9.54B
| $525K | ﹤0.01% | 12,850 -11,540 | -47% | -$471K |
|
250
iShares Russell Mid-Cap Growth ETF
IWP
$20.5B
| $512K | ﹤0.01% | +5,570 | New | +$512K |
|